These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 769850)

  • 1. Histochemical changes in the blood cells of schizophrenic patients under pimozide treatment.
    Stefanis CN; Issidorides MR
    Biol Psychiatry; 1976 Feb; 11(1):53-68. PubMed ID: 769850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of pimozide.
    Anumonye A; Onibuwe-Johnson T; Marinho AA
    West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):17-24. PubMed ID: 799401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimozide and the social behavior of schizophrenics.
    Lapierre YD; Lavallee J
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of serum neuroleptic concentration by radioreceptor assay: concurrent assessment of clinical psychosis ratings.
    Rosenblatt JE; Pert CB; Colison J; van Kammen DP; Scott R; Bunney WE
    Commun Psychopharmacol; 1979; 3(3):153-8. PubMed ID: 498748
    [No Abstract]   [Full Text] [Related]  

  • 8. A series of multicentric pilot trials with pimozide in psychiatric practice. IV. Pimozide in the treatment of patients with paranoid symptomatology.
    Amery W; Boom AJ; Huisman NG; Kuipers H; van der Wiel HJ; Reyntjens A
    Acta Psychiatr Belg; 1972 Nov; 72(6):677-84. PubMed ID: 4679634
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromatin alterations in leukocytes of first-episode schizophrenic patients.
    Kloukina-Pantazidou I; Havaki S; Chrysanthou-Piterou M; Kontaxakis VP; Papadimitriou GN; Issidorides MR
    Ultrastruct Pathol; 2010 May; 34(3):106-16. PubMed ID: 20455659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract]   [Full Text] [Related]  

  • 11. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 12. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
    Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
    J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
    [No Abstract]   [Full Text] [Related]  

  • 16. ABO blood group distribution in hebephrenic and paranoid schizophrenics. Preliminary data.
    Maj M; Morgese G; Del Vecchio M; Kemali D
    Acta Neurol (Napoli); 1980 Oct; 2(5):394-8. PubMed ID: 7457218
    [No Abstract]   [Full Text] [Related]  

  • 17. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
    Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
    Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
    Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
    [No Abstract]   [Full Text] [Related]  

  • 20. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.